For immunochemical detection of granzyme B
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Granzyme B Monoclonal Antibody (Clone 2F5F2D10)

Item No. 37067

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Synonyms
  • CTLA-1
  • Cytotoxic Serine Protease B
  • Cytotoxic T-lymphocyte Proteinase 2
  • Fragmentin-2
  • Granzyme-2
  • GrB
Immunogen
Recombinant human granzyme B
Clone Designation
2F5F2D10
Formulation (Request formulation change)
50, 100, or 200 µl of protein A-affinity purified monoclonal antibody
Storage Buffer
0.2 μm filtered solution in PBS
Host
Mouse
Applications
ELISA, IHC
Species Reactivity
((+)) Human
Shipping & Storage Information
Storage
-80°C
Shipping
Dry ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    50 µl

    $120

    Add

    100 µl

    $181

    Add

    200 µl

    $240

    Add
    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    Granzyme B is a serine protease that is involved in cytotoxic T lymphocyte- and natural killer cell-induced cell death.1,2 It localizes to cytoplasmic granules prior to release into the immunological synapse formed with a target cell.3,1 Granzyme B cleaves its substrates after an aspartate residue and targets caspase-3, caspase-8, and gasdermin E (GSDME), among others.1,2 It is involved in caspase-dependent and -independent apoptosis, necrosis, DNA fragmentation, pyroptosis, viral infection, and antitumor immunity.1,2,4 Knockout of the gene encoding granzyme B, GZMB, reduces disease severity in a mouse model of epidermolysis bullosa acquisita, an autoimmune disease characterized by blistering of the skin.5 Serum and synovial levels of granzyme B are elevated in patients with rheumatoid arthritis.6 Cayman’s Granzyme B Monoclonal Antibody (Clone 2F5F2D10) can be used for ELISA and immunohistochemistry (IHC) applications.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Barry, M., and Bleackley, R.C. Cytotoxic T lymphocytes: All roads lead to death. Nat. Rev. Immunol. 2(6), 401-409 (2002).

    2. Tsuchiya, K. Switching from apoptosis to pyroptosis: Gasdermin-elicited inflammation and antitumor immunity. Int. J. Mol. Sci. 22(1), 426 (2021).

    3. Pinkoski, M.J., Hobman, M., Heibein, J.A., et al. Entry and trafficking of granzyme B in target cells during granzyme B-perforin-mediated apoptosis. Blood 92(3), 1044-1054 (1998).

    4. Trapani, J.A., and Sutton, V.R. Granzyme B: Pro-apoptotic, antiviral and antitumor functions. Curr. Opin. Immunol. 15(5), 533-543 (2003).

    5. Hiroyasu, S., Zeglinski, M.R., Zhao, H., et al. Granzyme B inhibition reduces disease severity in autoimmune blistering diseases. Nat. Commun. 12(1), 302 (2021).

    6. Goldbach-Mansky, R., Suson, S., Wesley, R.A., et al. Raised granzyme B levels are associated with erosions in patients with early rheumatoid factor positive rheumatoid arthritis. Ann. Rheum. Dis. 64(5), 715-721 (2005).